TheStreet downgraded shares of Omega Healthcare Investors Inc. (NYSE:OHI) from a buy rating to a hold rating in a report published on Friday morning.

A number of other analysts have also recently weighed in on OHI. Thomas Weisel restated a buy rating and issued a $35.85 price target on shares of Omega Healthcare Investors in a report on Monday, August 1st. Vetr upgraded shares of Omega Healthcare Investors from a hold rating to a buy rating and set a $35.84 price target on the stock in a report on Tuesday, August 2nd. Zacks Investment Research cut shares of Omega Healthcare Investors from a buy rating to a hold rating in a report on Thursday, August 4th. SunTrust Banks Inc. raised their price target on shares of Omega Healthcare Investors from $38.00 to $42.00 and gave the company a buy rating in a report on Thursday, August 4th. Finally, JMP Securities lowered shares of Omega Healthcare Investors from an outperform rating to a market perform rating in a research report on Thursday, August 18th. They noted that the move was a valuation call. Five research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Omega Healthcare Investors has an average rating of Buy and a consensus price target of $36.59.

Analyst Recommendations for Omega Healthcare Investors (NYSE:OHI)

Omega Healthcare Investors (NYSE:OHI) opened at 29.46 on Friday. The firm has a 50 day moving average of $30.67 and a 200-day moving average of $33.47. Omega Healthcare Investors has a 52-week low of $26.96 and a 52-week high of $38.09. The company has a market capitalization of $5.75 billion, a price-to-earnings ratio of 18.74 and a beta of 0.59.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Monday, October 31st. The real estate investment trust reported $0.80 earnings per share for the quarter, missing analysts’ consensus estimates of $0.84 by $0.04. Omega Healthcare Investors had a net margin of 34.53% and a return on equity of 7.37%. The firm earned $224.60 million during the quarter, compared to the consensus estimate of $186.35 million. During the same quarter in the prior year, the business posted $0.79 earnings per share. The firm’s quarterly revenue was up 11.8% on a year-over-year basis. Equities analysts expect that Omega Healthcare Investors will post $3.38 EPS for the current year.

TRADEMARK VIOLATION WARNING: “Omega Healthcare Investors Inc. (OHI) Cut to Hold at TheStreet” was first posted by Financial Market News and is the propert of of Financial Market News. If you are viewing this story on another site, it was copied illegally and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this story can be viewed at http://www.financial-market-news.com/omega-healthcare-investors-inc-ohi-cut-to-hold-at-thestreet/1212090/.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, November 15th. Shareholders of record on Monday, October 31st were given a dividend of $0.61 per share. The ex-dividend date of this dividend was Thursday, October 27th. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.60. This represents a $2.44 dividend on an annualized basis and a yield of 8.28%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 155.42%.

In other Omega Healthcare Investors news, CEO C Taylor Pickett purchased 21,800 shares of Omega Healthcare Investors stock in a transaction on Friday, November 4th. The stock was bought at an average cost of $29.26 per share, with a total value of $637,868.00. Following the transaction, the chief executive officer now owns 276,261 shares of the company’s stock, valued at approximately $8,083,396.86. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Bernard J. Korman purchased 100,000 shares of Omega Healthcare Investors stock in a transaction on Friday, November 4th. The shares were acquired at an average cost of $29.29 per share, with a total value of $2,929,000.00. Following the completion of the transaction, the director now directly owns 774,685 shares in the company, valued at approximately $22,690,523.65. The disclosure for this purchase can be found here. Company insiders own 4.54% of the company’s stock.

A number of institutional investors have recently bought and sold shares of OHI. Brookfield Asset Management Inc. acquired a new position in Omega Healthcare Investors during the third quarter worth about $98,293,000. D.A. Davidson & CO. raised its position in Omega Healthcare Investors by 266.0% in the third quarter. D.A. Davidson & CO. now owns 14,268 shares of the real estate investment trust’s stock valued at $505,000 after buying an additional 10,370 shares during the period. Brinker Capital Inc. purchased a new position in Omega Healthcare Investors during the third quarter valued at $246,000. Scout Investments Inc. purchased a new position in Omega Healthcare Investors during the third quarter valued at $13,673,000. Finally, Delphi Management Inc. MA purchased a new position in Omega Healthcare Investors during the third quarter valued at $1,791,000. 82.81% of the stock is owned by institutional investors.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc (Omega) is a self-administered real estate investment trust (REIT). The Company invests in income producing healthcare facilities, long-term care facilities located throughout the United States and the United Kingdom. It operates through the segment, which consists of investments in healthcare-related real estate properties.

5 Day Chart for NYSE:OHI

Receive News & Ratings for Omega Healthcare Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.